8.89
전일 마감가:
$9.59
열려 있는:
$9.36
하루 거래량:
2.79M
Relative Volume:
0.65
시가총액:
$3.28B
수익:
$6.41B
순이익/손실:
$1.30B
주가수익비율:
1.7639
EPS:
5.04
순현금흐름:
$646.00M
1주 성능:
-29.83%
1개월 성능:
-31.61%
6개월 성능:
-45.78%
1년 성능:
-54.49%
오가논 & Co Stock (OGN) Company Profile
명칭
Organon Co
전화
551-430-6000
주소
30 HUDSON STREET, JERSEY CITY
OGN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
OGN
Organon Co
|
8.8977 | 3.28B | 6.41B | 1.30B | 646.00M | 5.04 |
![]()
LLY
Lilly Eli Co
|
825.70 | 739.75B | 49.00B | 11.11B | -1.27B | 12.29 |
![]()
JNJ
Johnson Johnson
|
154.90 | 370.90B | 89.33B | 21.81B | 18.57B | 8.99 |
![]()
ABBV
Abbvie Inc
|
196.46 | 340.25B | 57.37B | 4.20B | 17.83B | 2.35 |
![]()
NVO
Novo Nordisk Adr
|
69.37 | 277.97B | 42.09B | 14.65B | 10.11B | 3.2833 |
![]()
NVS
Novartis Ag Adr
|
113.47 | 222.45B | 53.22B | 12.86B | 14.85B | 6.39 |
오가논 & Co Stock (OGN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-09-06 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2023-11-03 | 다운그레이드 | Goldman | Buy → Neutral |
2023-09-21 | 개시 | Barclays | Overweight |
2023-03-16 | 개시 | Raymond James | Outperform |
2022-10-14 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2022-09-06 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2022-08-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
2022-04-27 | 개시 | Goldman | Buy |
2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
2021-10-07 | 개시 | Piper Sandler | Neutral |
2021-09-01 | 개시 | BofA Securities | Buy |
2021-07-22 | 개시 | Citigroup | Buy |
2021-06-15 | 개시 | JP Morgan | Neutral |
2021-06-11 | 개시 | Morgan Stanley | Equal-Weight |
2021-06-10 | 개시 | Evercore ISI | Outperform |
모두보기
오가논 & Co 주식(OGN)의 최신 뉴스
OGN INVESTIGATION ALERT: Investigation Launched into Organon & Co. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm - PR Newswire
Organon's (NYSE:OGN) Dividend Is Being Reduced To $0.02 - simplywall.st
Organon & Co. (NYSE:OGN) Q1 2025 Earnings Call Transcript - Insider Monkey
SLQT INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into SelectQuote, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - GlobeNewswire Inc.
OGN INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Organon projects over $1B in Nexplanon revenue for 2025 amid continued expansion - MSN
Why The Low Payout Ratio Did Not Stop The Dividend Cut For Organon (OGN) - Seeking Alpha
Organon downgraded to In Line from Outperform at Evercore ISI - MSN
Organon & Co. SEC 10-Q Report - TradingView
Evercore ISI Downgrades Organon to In Line From Outperform - marketscreener.com
Organon Stock Tumbles To Record Low On Downgrades And Dividend Cut: Retail Optimism Persists - MSN
Organon & Co. Earnings Call: Growth Amid Challenges - TipRanks
Organon (OGN) Faces Downgrade Following Dividend Reduction | OGN Stock News - GuruFocus
Organon Co earnings beat by $0.11, revenue fell short of estimates - Investing.com Australia
Organon (OGN) Faces Price Target Reduction and Dividend Cut | OG - GuruFocus
Organon & Co. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsOGN - Business Wire
OGN Investors Have Opportunity to Join Organon & Co. Fraud Investigation with the Schall Law Firm - Business Wire
Organon (OGN) Significantly Reduces Quarterly Dividend | OGN Sto - GuruFocus
Organon (OGN) Sees Growth in Nexplanon and Strategic Restructuri - GuruFocus
Organon slashes dividend - CNBC
Organon (OGN) Expands Board with New Appointment - GuruFocus
Organon (OGN) Set to Announce Q1 2025 Financial Results - GuruFocus
Organon (OGN) Slashes Quarterly Dividend by 92.9% - GuruFocus
Earnings call transcript: Organon Q1 2025 results show mixed signals By Investing.com - Investing.com India
Earnings call transcript: Organon Q1 2025 results show mixed signals - Investing.com
Organon & Co. 2025 Q1ResultsEarnings Call Presentation (NYSE:OGN) - Seeking Alpha
Organon (OGN) Reports Q1 Earnings: What Key Metrics Have to Say - Nasdaq
Organon Shares Fall After Lower Q1 Adjusted Earnings, Revenue - marketscreener.com
Organon (NYSE:OGN) Posts Better-Than-Expected Sales In Q1 But Stock Drops 23.5% - Yahoo Finance
Organon stock hits 52-week low at $10.18 amid market challenges - Investing.com
Organon & Co Q1 2025 Earnings: Revenue Beats at $1.513 Billion, EPS Misses at $0.33 - GuruFocus
Organon & Co reports results for the quarter ended March 31Earnings Summary - TradingView
Organon Q1 2025 slides: Women’s Health growth offsets revenue headwinds By Investing.com - Investing.com India
Organon Q1 2025 slides: Women’s Health growth offsets revenue headwinds - Investing.com Australia
Organon drops after dividend cut - MSN
Organon stock drops after dividend cut (OGN:NYSE) - Seeking Alpha
Organon (OGN) Q1 Earnings Surpass Estimates - Yahoo Finance
Organon: Q1 Earnings Snapshot - San Antonio Express-News
Organon in charts: Weak Q1 revenue across major business lines and regions (NYSE:OGN) - Seeking Alpha
Organon stock falls as revenue misses estimates, guidance disappoints By Investing.com - Investing.com Nigeria
Organon stock falls as revenue misses estimates, guidance disappoints - Investing.com
Organon Reports Results for the First Quarter Ended March 31, 2025 - Business Wire
Organon & Co. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Organon Q1 2025 Earnings Preview - MSN
Organon Q1 2025 Earnings Preview (OGN:NYSE) - Seeking Alpha
Organon (OGN) Q1 Earnings: What To Expect - Yahoo Finance
Organon (NYSE:OGN) Use Of Debt Could Be Considered Risky - simplywall.st
Organon & Co (OGN) Shares Up 2.99% on Apr 28 - GuruFocus
Countdown to Organon (OGN) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance
Organon (OGN) Ascends But Remains Behind Market: Some Facts to Note - MSN
Organon & Co Receives a Shareholder Proposal from The New York City Carpenters Pension Fund - marketscreener.com
오가논 & Co (OGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):